In Depth

Are PBMs to blame for high drug prices in the US?

Into the unknown: how quickly can vaccines be developed for Disease X

US negotiations for first round of drugs reveal $6bn in Medicare savings

Emerging microbiome market – unlocking new frontiers

Build or buy? key considerations for in-house manufacturing